相似文献
1
Non-Hodgkin's lymphoma. I: Characterisation and treatment.
BMJ. 1992 Jun 27;304(6843):1682-6. doi: 10.1136/bmj.304.6843.1682.
2
Relapsed large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2007 Apr;18 Suppl 2:ii57-8. doi: 10.1093/annonc/mdm038.
3
Newly diagnosed large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2007 Apr;18 Suppl 2:ii55-6. doi: 10.1093/annonc/mdm037.
4
[Prognostic factors of invasive non-Hodgkin's lymphoma].
Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):461-3.
5
Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic type.
N Engl J Med. 1979 Oct 25;301(17):924-8. doi: 10.1056/NEJM197910253011706.
6
Classification of non-Hodgkin's lymphomas in children.
Semin Diagn Pathol. 1995 Nov;12(4):303-13.
7
Chemotherapy of non-Hodgkin's aggressive lymphomas.
Semin Hematol. 1994 Jan;31(1):46-69.
8
[Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):142-4.
9
Combination chemotherapy of unfavourable prognosis non-Hodgkin's lymphomas (NHL). A retrospective study of 53 cases.
Haematologica. 1981 Dec;66(6):740-9.
10
Non-Hodgkin's lymphoma.
Semin Oncol Nurs. 1998 Nov;14(4):273-83. doi: 10.1016/s0749-2081(98)80005-3.
引用本文的文献
1
Ophthalmoplegia as an unusual initial symptom of non-Hodgkins' lymphoma in the head and neck.
Eur Arch Otorhinolaryngol. 1997;254(9-10):470-3. doi: 10.1007/BF02439984.
2
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
Br J Cancer. 1994 Jun;69(6):1088-93. doi: 10.1038/bjc.1994.213.
3
Primary small bowel non-Hodgkin's lymphoma with biliary and pancreatic duct obstruction.
Indian J Pediatr. 1994 Jan-Feb;61(1):96-100. doi: 10.1007/BF02753569.
4
Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.
Drugs. 1993 May;45(5):788-856. doi: 10.2165/00003495-199345050-00011.
5
Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study.
Br J Cancer. 1995 Sep;72(3):757-65. doi: 10.1038/bjc.1995.406.
6
Non-Hodgkin's lymphoma. II: Management problems.
BMJ. 1992 Jul 4;305(6844):39-42. doi: 10.1136/bmj.305.6844.39.
本文引用的文献
1
2
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):125-34. doi: 10.1016/0360-3016(80)90027-9.
3
Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience.
Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):489-97. doi: 10.1016/0360-3016(84)90028-2.
4
Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.
J Clin Oncol. 1984 Aug;2(8):898-902. doi: 10.1200/JCO.1984.2.8.898.
5
Report of the Committee on Hodgkin's Disease Staging Classification.
Cancer Res. 1971 Nov;31(11):1860-1.
6
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
Ann Intern Med. 1972 Feb;76(2):227-34. doi: 10.7326/0003-4819-76-2-227.
7
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
Cancer. 1971 Aug;28(2):306-17. doi: 10.1002/1097-0142(197108)28:2<306::aid-cncr2820280208>3.0.co;2-n.
8
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
Cancer. 1970 May;25(5):1018-25. doi: 10.1002/1097-0142(197005)25:5<1018::aid-cncr2820250505>3.0.co;2-a.
9
Non-Hodgkin's lymphomas. V. Results of radiotherapy.
Cancer. 1973 Sep;32(3):682-91. doi: 10.1002/1097-0142(197309)32:3<682::aid-cncr2820320322>3.0.co;2-m.
10
Long-term survival of patients with localized diffuse histiocytic lymphoma.
J Clin Oncol. 1985 Oct;3(10):1309-17. doi: 10.1200/JCO.1985.3.10.1309.
Zotero 插件